Monadnock NH
FDA contradicts Pfizer's advice on 2nd course of COVID drug
There is "no evidence" that a second course of Pfizer Inc.'s Paxlovid will help COVID-19 patients whose symptoms return after an initial course of the antiviral, a U.S. Food and Dr…
